menu
    • menu

    Company profile for Ipca Laboratories

    Alchem offers Phytochemical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs. Renowned for its exceptional research and development capabilities, Ipca is ded...
    Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pharmaceutical landscape, specializing in the manufacturing and commercialization of a diverse range of healthcare products, including APIs, formulations, and generic drugs. Renowned for its exceptional research and development capabilities, Ipca is dedicated to delivering high-quality and cost-effective medications across various therapeutic domains, including anti-malarial, anti-infective, anti-inflammatory, cardiovascular, central nervous system, among others.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ipca Laboratoriesindia-flag Flag
    Country
    Country
    India
    Address
    Address
    Kandivli (West), Mumbai – 400 067, Maharashtra
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ipca.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ipca/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    APGA Annual Conference

    Not Confirmed

    envelop Contact Supplier

    APGA Annual Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    "50 Years of Innovation: Mikart

    mic"50 Years of Innovation: Mikart's legacy and what's next in CDMO excellence"

    This week, SpeakPharma interviews Michael Kallelis, CEO of Mikart, a leading contract development and manufacturing organization (CDMO) celebrating its 50th anniversary in the pharmaceutical industry. Based in the United States, Mikart has built a reputation for technical expertise, flexible business terms, and specialized capabilities in pharmaceutical development services. In this exclusive interview, Kallelis discusses how Mikart maintains its competitive edge through its Pharmaceutical Development Services team, quality control framework, and commitment to customized business solutions. Kallelis also explores the company's focus on liquid suspensions manufacturing, driven by growing demand from aging populations and pediatric patients, and explains how Mikart balances traditional family business values with modern innovation. HIGHLIGHTS// celebrating its 50th anniversary/ reputation for technical expertise/ how Mikart maintains its competitive edge Mikart is celebrating 50 years in business this year — what are some of the major milestones that have shaped the company's journey? Over our 50-year history, we've celebrated many memorable milestones, but one of the most significant in recent years has been achieving our growth objectives. This success was driven by the strategic expansion of our Pharmaceutical Development Services team, the completion of full aggregate serialization in our packaging department, modernization of our IT systems, enhanced productivity, and our ability to attract both new and returning customers. HIGHLIGHTS// expansion of our Pharmaceutical Development Services team/ completion of full aggregate serialization/ attract both new and returning customers How has Mikart maintained its competitive edge in a constantly evolving pharmaceutical landscape? Our customers consistently tell us that what sets us apart is our technical expertise, high service level, and flexible, customized business terms. At the core of our competitiveness is our focus on Pharmaceutical Development Services (PDS). Mikart's PDS opinion leaders are actively engaged in business development and form early, collaborative relationships with our customers' technical teams. From the outset, our prospects and clients work directly with Mikart's experienced formulation chemists, analytical method developers, and process-oriented engineers to design robust, reproducible, and efficient processes. This hands-on development approach is supported by a comprehensive quality control testing framework — covering raw material testing, in-process checks, on-site microbiological testing, and in-house stability studies. Oversight is provided by our robust Quality Management System, managed by a dedicated Quality Assurance and Regulatory Affairs team. The result is disciplined problem-solving, timely FDA submissions, and a "right-first-time" philosophy that accelerates time-to-market. We operate with a strong sense of urgency and consistently deliver a high level of customer satisfaction. What truly differentiates Mikart is our commitment to customized business terms that eliminate common roadblocks seen with other CDMOs. Our secret sauce is our exceptional service and flexibility in helping our customers bring innovative medicines to patients. HIGHLIGHTS// technical expertise, high service level/ flexible, customized business terms/ comprehensive quality control testing framework/ dedicated Quality Assurance and Regulatory Affairs team/ timely FDA submissions/ accelerates time-to-market What capabilities or services does Mikart offer today that didn't exist 10 or 20 years ago? Mikart was an early leader in serialization, implementing full capabilities well ahead of the industry timeline. This proactive approach has kept our packaging team in high demand. We also upgraded our tablet compression equipment to enhance both speed and reliability. To support growing development needs, we invested in new lab-scale development equipment, unit dose cup filling, sachet packaging, low-humidity suites, and a brand-new suite dedicated to closed-system manufacturing of liquids and suspensions. Most recently, we launched a multi-million dollar expansion of our packaging lines to support higher-speed tablet filling, powder-in-bottle formats, and new liquid fill capabilities. HIGHLIGHTS// early leader in serialization/ upgraded our tablet compression equipment/ multi-million dollar expansion of our packaging lines Why are liquid suspensions becoming such a key focus, and how is Mikart positioned? Formulating suspensions is a complex process that requires specialized expertise and equipment. According to our customers, few mid-market CDMOs do it well — and Mikart is one of them. There is growing industry demand for high-quality suspension manufacturing, driven by the needs of the aging baby boomer population and pediatric patients. For both groups, swallowing tablets or capsules can be difficult, making oral liquid suspensions a more practical alternative. In addition to being easier to administer, suspensions offer pharmacological advantages and can improve dosing compliance. Enhanced flavoring techniques further improve the patient experience — especially for children and infants — by making medicines more palatable. HIGHLIGHTS// growing industry demand for high-quality suspension manufacturing/ suspensions offer pharmacological advantages/ improve dosing compliance How does Mikart balance tradition with innovation to meet modern customer demands? At Mikart, we work hard to preserve the values of a traditional family business, even as we continue to modernize. Our goal is to make every customer feel like they are our top priority. Each customer is supported by a dedicated project manager who serves as their primary point of contact, along with direct access to key team members across departments. This structure ensures our customers are never isolated from our subject matter experts and can get timely, accurate answers to their questions. We're also mindful of the "technology trap" — the tendency to pursue every new innovation at the expense of focus and efficiency. Instead, we rely on market data and customer trends to guide our investments, enabling us to concentrate our resources and capital on technologies that meet real market needs. HIGHLIGHTS// customer is supported by a dedicated project manager/ customers are never isolated from our subject matter experts/ we rely on market data and customer trends to guide our investments/ meet real market needs Looking ahead, what's in store for Mikart in the next 5-10 years? Mikart's strategic plan is now in full motion, and with the momentum we've built, 50 percent growth is within reach. This projection is backed by a strong pipeline of annual FDA filings, a growing customer base, and a robust portfolio of active Pharmaceutical Development Services projects. As we grow, we remain committed to delivering exceptional service and continuously evolving to meet the changing needs of our customers. With renewed political emphasis on domestic manufacturing for the US market, we are ideally positioned to support the rapid, cost-effective development and production of high-quality medicines here at home. As we approach our 50th anniversary in the CDMO industry, we celebrate our legacy and look forward with optimism to the opportunities ahead in the next 5 to 10 years. HIGHLIGHTS// 50 percent growth is within reach/ strong pipeline of annual FDA filings 

    Impressions: 42

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence

    PharmaCompass
    17 Jul 2025
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    ReelPharmaYour Global Ally in the Pharmaceutical IndustryYour Global Ally in the Pharmaceutical Industry

    Your Global Ally in the Pharmaceutical Industry
    Your Global Ally in the Pharmaceutical Industry

    reelYour Global Ally in the Pharmaceutical Industry

    This PharmaReel highlights Gentec Pharmaceutical's expertise in generic APIs, HPAPIs, and prostaglandins with more than 30 years of experience. Operating from EU-GMP-certified facilities, the company exports to over 70 countries worldwide.

    Impressions: 1331

    read-more

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    CDMO Activity Tracker: Veranova, Carbogen lead ADC investments; Axplora, Polfa Tarchomin, Famar expand European footprint

    CDMO Activity Tracker: Veranova, Carbogen lead ADC investments; Axplora, Polfa Tarchomin, Famar expand European footprint

    During the second quarter (Q2) of 2025, contract development and manufacturing organizations (CDMOs) made substantial investments in specialized therapeutic manufacturing. The quarter also saw CDMOs pursue high-value, complex manufacturing niches, particularly in antibody-drug conjugates (ADCs), cell and gene therapies (CGTs) and oligonucleotides.Alongside these trends, Q2 also saw CDMOs strengthen their footprint in the United States amid concerns over rising tariffs and unpredictable trade policies being enforced by the Trump administration.Regeneron Pharmaceuticals committed over US$ 3 billion through a 10-year agreement with Fujifilm Diosynth Biotechnologies to nearly double its US manufacturing capacity for biologics. Under this agreement, Fujifilm will manufacture and supply drug products for Regeneron at its large-scale facility in Holly Springs, North Carolina.Thermo Fisher Scientific announced plans to invest an additional US$ 2 billion in the US over four years, reinforcing its manufacturing and R&D capabilities. With 64 facilities spread across 37 states, Thermo Fisher aims to bolster American innovation and competitiveness. Similarly, Piramal Pharma announced a US$ 90 million investment plan for expanding two facilities in the US, thereby bringing its total investment in the country to US$ 570 million. View CDMO Activity Tracker for Q2 2025 (Free Excel Available)Veranova, Carbogen lead ADC wave; Axplora doubles down on HPAPI production in ItalyThe quarter saw substantial investments in ADC manufacturing. Veranova announced a US$ 20 million investment in bioconjugation development and cGMP manufacturing capacity at its Devens, Massachusetts campus. With this investment, Veranova will be able to provide a more comprehensive suite of services to its partners developing ADCs and other bioconjugates. Veranova’s total investment in the Devens facility now stands at over US$ 50 million. Swiss CDMO Carbogen announced a US$ 31 million co-investment with an unnamed Japanese investor to expand its capabilities across its Aarau and Neuland (Switzerland) facilities. The facility will address increasing demand for complex and high-value compounds such as ADC drug linkers.Axplora announced a further €35 million (US$ 41 million) expansion of its Farmabios site in Italy, doubling the facility to approximately 108,000 square meters by mid-2026. This investment raises its total spend on the site to over €80 million (US$ 94.05 million) since 2019, supporting the production of highly potent active pharmaceutical ingredients (HPAPIs). Farmabios now stands as a key hub in Axplora’s global CDMO network.Polish pharmaceutical manufacturer Polfa Tarchomin is positioning itself as a significant player in the European CDMO market through its investment in the Center for Development and Production of Highly Potent Drugs. This 12,000 square meter facility has two state-of-the-art production lines designed for filling vials and pre-filled syringes with an annual capacity of 26 million product units.Skyepharma’s projected annual revenues from oncology-linked activities touched €10 million (US$ 11.2 million). The CDMO’s facility in Saint-Quentin-Fallavier is equipped to handle cytotoxic and cytostatic compounds, and is one of the few facilities in France capable of managing HPAPIs for oral anticancer treatments. View CDMO Activity Tracker for Q2 2025 (Free Excel Available) Athena acquires Medipha Santé, Famar buys MiP Pharma’s German site to strengthen European footprintDuring the quarter, several CDMOs enhanced their strategic capabilities through M&As. Athena Pharmaceutiques acquired  Medipha Santé to build a fully integrated pharmaceutical services platform in Europe. Based in Paris, Athena has strengthened its commercial and regulatory toolbox by bringing aboard Medipha Santé’s 35-strong team, which supports over 100 partner organizations and files approximately 350 dossiers annually with ANSM and other European agencies. With this integration, Athena positions itself as a one-stop CDMO partner.With the acquisition of MiP Pharma’s sterile manufacturing site in Homburg, Germany, the Famar Group has expanded its capabilities in aseptic and lyophilized fill-and-finish operations. The acquisition has strengthened Famar’s position in sterile drug manufacturing. The CDMO now has seven manufacturing facilities in Europe.PCI Pharma Services’ acquisition of Ajinomoto Althea has established a world-class, large-scale manufacturing hub in the San Diego region with state-of-the-art aseptic facilities for prefilled syringes, cartridges and high-potent formulations such as ADCs. PCI Pharma is now amongst the few US-based CDMOs capable of comprehensive ADC manufacturing.Samsung Biologics’ strategic spinoff of its biosimilar business stood out as a significant corporate restructuring exercise during the quarter. The separation of Samsung Bioepis, tentatively renamed Samsung Epis Holdings, aims to enhance Samsung Biologics’ strategic focus and build client trust, as it eliminates potential conflicts between CDMO services and proprietary drug development. The move came after Samsung Biologics inked a contract worth 737.3 billion Korean won (US$ 518 million) with an undisclosed US pharmaceutical company.WuXi Biologics announced a US$ 167 million divestment of its German facility to Terumo and broke ground on a microbial production plant in China. National Resilience, which was launched five years ago as the US drug manufacturer dedicated to broadening access to medicines and protecting biopharma supply chains, said it is shuttering six of its 10 facilities. The company said the sites were “not being fully utilized.” View CDMO Activity Tracker for Q2 2025 (Free Excel Available) MilliporeSigma, Simtra form 5-year ADC alliance; Silexion partners Catalent for siRNA developmentMerck KGaA’s MilliporeSigma and Simtra struck a five-year strategic alliance, combining expertise across the ADC value chain to reduce development timelines and complexity for biopharmaceutical companies. Viralgen collaborated with Trogenix to rapidly scale product supply for TGX-007, an AAV gene therapy for glioblastoma (a type of cancer of the brain and spinal cord).  Silexion announced a collaboration with Catalent for small interfacing RNA (siRNA) development and manufacturing. Catalent’s Limoges (France) facility will conduct formulation development and clinical manufacturing for Silexion’s SIL204 candidate, supporting both systemic and intra-tumoral delivery formulations.Skyepharma’s collaboration with Eneapharm through the Skyehub platform aims to support the treatment of patients suffering from exocrine pancreatic insufficiency, including those affected by cystic fibrosis or pancreatic cancer. Orion Corporation reached an agreement with Shilpa Biocare for the distribution of recombinant human albumin in Europe.Meanwhile, Aenova announced the launch of its Aenovation program, an initiative designed to fast-track early development of pharmaceutical formulations. The program addresses the critical challenges of bioavailability and time-to-market faced by poorly soluble drug candidates. View CDMO Activity Tracker for Q2 2025 (Free Excel Available) Our view The quarter saw CDMO developments mimic the broader trends in the pharmaceutical industry, such as onshoring of critical manufacturing capabilities in the US, consolidation of specialized expertise through strategic partnerships, and the relentless focus on emerging therapeutic modalities that promise to transform patient care. With CDMOs continuing to invest in next-generation manufacturing capabilities, we expect the sector to play a crucial role in drug innovation. 
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 1165

    https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint

    #PharmaFlow by PHARMACOMPASS
    10 Jul 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Ipca’s Generics Metoprolol Succinate Approved in US
    Ipca’s Generics Metoprolol Succinate Approved in US

    25 Jun 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206980

    FDA
    25 Jun 2025
    Share Share
    Ipca Labs expects its US generics sales to touch $200 million soon
    Ipca Labs expects its US generics sales to touch $200 million soon

    21 Aug 2024

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/ipca-labs-expects-its-us-generics-sales-to-touch-200-million-soon/articleshow/112662992.cms

    ECONOMICTIMES
    21 Aug 2024
    Share Share
    Ipca Laboratories`s Generics Etodolac Receives Approval in US
    Ipca Laboratories`s Generics Etodolac Receives Approval in US

    01 Aug 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205448

    FDA
    01 Aug 2024
    Share Share
    Ipca Labs Generic Risperidone Receives Approval in US
    Ipca Labs Generic Risperidone Receives Approval in US

    26 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205104

    FDA
    26 Jun 2024
    Share Share
    Ipca Labs's Generic Alendronate Sodium Receives Approval in US
    Ipca Labs's Generic Alendronate Sodium Receives Approval in US

    04 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206387

    FDA
    04 Jun 2024
    Share Share
    Ipca Labs Generic Levocetirizine Dihydrochloride Receives Approval in The US
    Ipca Labs Generic Levocetirizine Dihydrochloride Receives Approval in The US

    06 May 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204626

    FDA
    06 May 2024
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Alendronate Sodium

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    APGA Annual Conference
    Not Confirmed
    arrow

    Alendronate Sodium

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    APGA Annual Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-11-14

    Pay. Date : 2013-07-30

    DMF Number : 21008

    Submission : 2007-12-03

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2008-090 - Rev 02

    Issue Date : 2021-04-27

    Type : Chemical

    Substance Number : 1564

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 219MF10310

    Registrant's Address : 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067, India

    Initial Date of Registration : 2007-10-05

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2022-12-30

    Valid Till : 2025-08-05

    Written Confirmation Number : WC-0236

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 57451-1157

    Start Marketing Date : 2013-08-16

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Propranolol Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    APGA Annual Conference
    Not Confirmed
    arrow

    Propranolol Hydrochloride

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    APGA Annual Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-07-31

    Pay. Date : 2013-07-23

    DMF Number : 15849

    Submission : 2002-02-01

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2002-026 - Rev 06

    Issue Date : 2023-12-06

    Type : Chemical

    Substance Number : 568

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 218MF10174

    Registrant's Address : 48, Kandivli Industrial Estate, Kandivli (W), Mumbai 400 067, India

    Initial Date of Registration : 2006-02-08

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2023-09-25

    Valid Till : 2026-03-20

    Written Confirmation Number : WC-0453

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 57451-1216

    Start Marketing Date : 2021-06-17

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Furosemide

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    APGA Annual Conference
    Not Confirmed
    arrow

    Furosemide

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    APGA Annual Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-07-23

    Pay. Date : 2013-07-15

    DMF Number : 10109

    Submission : 1993-02-23

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 1998-020 - Rev 07

    Issue Date : 2019-10-30

    Type : Chemical

    Substance Number : 391

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 225MF10191

    Registrant's Address : 48, Kandivli Industrial Estate, Kandivli (W), Mumbai 400 067, India

    Initial Date of Registration : 2013-10-09

    Latest Date of Registration :

    EU-WCInactive-api
    ✖

    Date of Issue : 2022-06-08

    Valid Till : 2025-07-02

    Written Confirmation Number : WC-0091n

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 57451-0006

    Start Marketing Date : 2012-02-28

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Glimepiride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    APGA Annual Conference
    Not Confirmed
    arrow

    Glimepiride

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    APGA Annual Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-02-20

    Pay. Date : 2013-11-06

    DMF Number : 20037

    Submission : 2006-12-19

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2007-036 - Rev 01

    Issue Date : 2019-12-18

    Type : Chemical

    Substance Number : 2223

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 226MF10075

    Registrant's Address : 48, Kandivli Industrial Estate, Kandivli (W), Mumbai 400 067, India

    Initial Date of Registration : 2014-04-02

    Latest Date of Registration :

    EU-WCInactive-api
    ✖

    Date of Issue : 2022-06-08

    Valid Till : 2025-07-02

    Written Confirmation Number : WC-0091n

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 57451-1151

    Start Marketing Date : 2012-02-15

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Sungwoo Chemical Co., Ltd.

    Registration Date : 2013-10-20

    Registration Number : 20080627-78-D-31-14(5)

    Manufacturer Name : IPCA Laboratories Limited

    Manufacturer Address : PO Sejavta, District-Ratlam (MP) 457001, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Hydrochlorothiazide

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    APGA Annual Conference
    Not Confirmed
    arrow

    Hydrochlorothiazide

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    APGA Annual Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2012-11-11

    Pay. Date : 2012-12-05

    DMF Number : 16707

    Submission : 2003-07-07

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2004-013 - Rev 06

    Issue Date : 2023-08-29

    Type : Chemical

    Substance Number : 394

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 224MF10171

    Registrant's Address : 48, Kandivli Industrial Estate, Kandivli (W), Mumbai 400 067, India

    Initial Date of Registration : 2012-08-16

    Latest Date of Registration :

    EU-WCInactive-api
    ✖

    Date of Issue : 2022-06-08

    Valid Till : 2025-07-02

    Written Confirmation Number : WC-0091n

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 57451-1142

    Start Marketing Date : 2023-12-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Aging Life Science Co., Ltd.

    Registration Date : 2021-03-10

    Registration Number : 20210310-209-J-862

    Manufacturer Name : IPCA Laboratories Limited

    Manufacturer Address : Sejavta Dist. Ratlam(MP)PIN. 457 002 India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Losartan Potassium

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    APGA Annual Conference
    Not Confirmed
    arrow

    Losartan Potassium

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    APGA Annual Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 16526

    Submission : 2003-04-05

    Status : Inactive

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R0-CEP 2019-224 - Rev 03

    Issue Date : 2023-01-12

    Type : Chemical

    Substance Number : 2232

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 222MF10266

    Registrant's Address : 48, Kandivli Industrial Estate, Kandivli (W), Mumbai 400 067, India

    Initial Date of Registration : 2010-12-08

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2024-06-03

    Valid Till : 2027-06-03

    Written Confirmation Number : WC-0464

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 57451-1211

    Start Marketing Date : 2024-12-27

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Ildong Pharmaceutical Co., Ltd.

    Registration Date : 2020-06-29

    Registration Number : 20100226-122-G-47-16(6)

    Manufacturer Name : IPCA Laboratories Limited@Ipca Laboratories Limited@[Manufacturer of intermediate (Losartan base)] Ipca Laboratories Limited, Mahad

    Manufacturer Address : PO Sejavta, District-Ratlam (MP) 457001, India@Block No. 123, 131 & 132, Village-Ranu, Tal-Padra, City : Ranu, Dist : Vadodara, Gujarat state, India@[Manufacturer of intermediate (Losartan base)] C-89 to C-95, MIDC Industrial Area, Mahad Dist. Raigad (MS)-402309 (Maharashtra), India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Metoprolol Tartrate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    APGA Annual Conference
    Not Confirmed
    arrow

    Metoprolol Tartrate

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    APGA Annual Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 15850

    Submission : 2002-02-02

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2003-091 - Rev 04

    Issue Date : 2023-03-16

    Type : Chemical

    Substance Number : 1028

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 221MF10151

    Registrant's Address : 48, Kandivli Industrial Estate, Kandivli (W), Mumbai 400 067, INDIA

    Initial Date of Registration : 2009-07-09

    Latest Date of Registration :

    EU-WCInactive-api
    ✖

    Date of Issue : 2022-06-08

    Valid Till : 2025-07-02

    Written Confirmation Number : WC-0091n

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 57451-1163

    Start Marketing Date : 2019-11-08

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Atenolol

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    APGA Annual Conference
    Not Confirmed
    arrow

    Atenolol

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    APGA Annual Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 7821

    Submission : 1988-12-15

    Status : Inactive

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 1998-024 - Rev 06

    Issue Date : 2023-11-10

    Type : Chemical

    Substance Number : 703

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 218MF10439

    Registrant's Address : 48, Kandivli Industrial Estate, Kandivli (W), Mumbai 400 067, India

    Initial Date of Registration : 2006-04-27

    Latest Date of Registration :

    EU-WCInactive-api
    ✖

    Date of Issue : 2022-06-08

    Valid Till : 2025-07-02

    Written Confirmation Number : WC-0091n

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 57451-1115

    Start Marketing Date : 2012-02-22

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Shinil Pharmaceutical Co., Ltd.

    Registration Date : 2012-10-11

    Registration Number : 20050831-34-B-91-04(12)

    Manufacturer Name : Ipca Laboratories Limited.

    Manufacturer Address : PO Sejavta Dist. Ratlam(MP)PIN. 457 002, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Chlorthalidone

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    APGA Annual Conference
    Not Confirmed
    arrow

    Chlorthalidone

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    APGA Annual Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-07-23

    Pay. Date : 2013-07-15

    DMF Number : 17808

    Submission : 2004-11-03

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2006-004 - Rev 00

    Issue Date : 2013-04-19

    Type : Chemical

    Substance Number : 546

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2024-06-10

    Valid Till : 2027-06-09

    Written Confirmation Number : WC-0583

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 57451-1134

    Start Marketing Date : 2013-10-26

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Daehan New Pharm Co., Ltd.

    Registration Date : 2024-02-23

    Registration Number : 20180406-209-J-47(6)

    Manufacturer Name : IPCA Laboratories Limited

    Manufacturer Address : PO Sejavta Dist. Ratlam(MP)-457 001, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Metoclopramide Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    APGA Annual Conference
    Not Confirmed
    arrow

    Metoclopramide Hydrochloride

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    APGA Annual Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-01-11

    Pay. Date : 2012-12-10

    DMF Number : 7581

    Submission : 1988-07-15

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2004-075 - Rev 05

    Issue Date : 2024-03-12

    Type : Chemical

    Substance Number : 674

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2024-06-10

    Valid Till : 2027-06-09

    Written Confirmation Number : WC-0583

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 57451-1119

    Start Marketing Date : 2012-06-02

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Ipca Laboratories and get a quotation

    Ipca Laboratories is a supplier offers 173 products (APIs, Excipients or Intermediates).

    Find a price of Alendronate Sodium bulk with DMF, CEP, JDMF, WC offered by Ipca Laboratories

    Find a price of Propranolol Hydrochloride bulk with DMF, CEP, JDMF, WC offered by Ipca Laboratories

    Find a price of Furosemide bulk with DMF, CEP, JDMF offered by Ipca Laboratories

    Find a price of Glimepiride bulk with DMF, CEP, JDMF offered by Ipca Laboratories

    Find a price of Hydrochlorothiazide bulk with DMF, CEP, JDMF offered by Ipca Laboratories

    Find a price of Losartan Potassium bulk with CEP, JDMF, WC offered by Ipca Laboratories

    Find a price of Metoprolol Tartrate bulk with DMF, CEP, JDMF offered by Ipca Laboratories

    Find a price of Atenolol bulk with CEP, JDMF offered by Ipca Laboratories

    Find a price of Chlorthalidone bulk with DMF, CEP, WC offered by Ipca Laboratories

    Find a price of Famotidine bulk with CEP, JDMF, WC offered by Ipca Laboratories

    Find a price of Metoclopramide Hydrochloride bulk with DMF, CEP, WC offered by Ipca Laboratories

    Find a price of Nifedipine bulk with CEP, JDMF, WC offered by Ipca Laboratories

    Find a price of Telmisartan bulk with DMF, CEP, WC offered by Ipca Laboratories

    Find a price of Allopurinol bulk with DMF, CEP offered by Ipca Laboratories

    Find a price of Amlodipine Besylate bulk with DMF, CEP offered by Ipca Laboratories

    Find a price of Carvedilol bulk with DMF, CEP offered by Ipca Laboratories

    Find a price of Cetirizine Dihydrochloride bulk with DMF, CEP offered by Ipca Laboratories

    Find a price of Chloroquine Phosphate bulk with DMF, CEP offered by Ipca Laboratories

    Find a price of Chlorthalidone bulk with DMF, CEP offered by Ipca Laboratories

    Find a price of Etodolac bulk with CEP, WC offered by Ipca Laboratories

    Find a price of Hydroxychloroquine Sulphate bulk with DMF, CEP offered by Ipca Laboratories

    Find a price of Hydroxyzine Dihydrochloride bulk with DMF, CEP offered by Ipca Laboratories

    Find a price of Losartan Potassium bulk with DMF, CEP offered by Ipca Laboratories

    Find a price of Olanzapine bulk with DMF, CEP offered by Ipca Laboratories

    Find a price of Primaquine Diphosphate bulk with DMF, CEP offered by Ipca Laboratories

    Find a price of Proguanil bulk with DMF, CEP offered by Ipca Laboratories

    Find a price of Pyrantel Pamoate bulk with DMF, CEP offered by Ipca Laboratories

    Find a price of Pyrimethamine bulk with DMF, CEP offered by Ipca Laboratories

    Find a price of Quetiapine Hemifumarate bulk with DMF, CEP offered by Ipca Laboratories

    Find a price of Torsemide bulk with DMF, CEP offered by Ipca Laboratories

    Find a price of Trimethoprim bulk with DMF, CEP offered by Ipca Laboratories

    Find a price of Valsartan bulk with CEP, WC offered by Ipca Laboratories

    Find a price of Venlafaxine Hydrochloride bulk with DMF, CEP offered by Ipca Laboratories

    Find a price of Warfarin Sodium bulk with DMF, CEP offered by Ipca Laboratories

    Find a price of Bendroflumethiazide bulk with CEP offered by Ipca Laboratories

    Find a price of Benzarone bulk with JDMF, WC offered by Ipca Laboratories

    Find a price of Benzbromarone bulk with JDMF, WC offered by Ipca Laboratories

    Find a price of Bisoprolol Fumarate bulk with CEP offered by Ipca Laboratories

    Find a price of Citalopram Hydrobromide bulk with CEP offered by Ipca Laboratories

    Find a price of Donepezil bulk with CEP, WC offered by Ipca Laboratories

    Find a price of Fenofibrate bulk with CEP offered by Ipca Laboratories

    Find a price of Fluconazole bulk with CEP offered by Ipca Laboratories

    Find a price of Flumequine bulk with CEP offered by Ipca Laboratories

    Find a price of Fluoxetine Hydrochloride bulk with DMF, CEP offered by Ipca Laboratories

    Find a price of Hydrochlorothiazide bulk with DMF, CEP offered by Ipca Laboratories

    Find a price of Indapamide bulk with CEP offered by Ipca Laboratories

    Find a price of Meloxicam bulk with CEP, WC offered by Ipca Laboratories

    Find a price of Mesalazine bulk with DMF, CEP offered by Ipca Laboratories

    Find a price of Mesalazine bulk with CEP offered by Ipca Laboratories

    Find a price of Metformin bulk with CEP offered by Ipca Laboratories

    Find a price of Methylphenidate Hydrochloride bulk with CEP offered by Ipca Laboratories

    Find a price of Metoprolol Succinate bulk with CEP offered by Ipca Laboratories

    Find a price of Nabumetone bulk with CEP offered by Ipca Laboratories

    Find a price of Ondansetron Hydrochloride bulk with DMF, CEP offered by Ipca Laboratories

    Find a price of Paroxetine Hydrochloride bulk with CEP offered by Ipca Laboratories

    Find a price of Trazodone Hydrochloride bulk with DMF, CEP offered by Ipca Laboratories

    Find a price of Triamterene bulk with DMF, CEP offered by Ipca Laboratories

    Find a price of Warfarin Sodium bulk with CEP offered by Ipca Laboratories

    Find a price of Zaltoprofen bulk with JDMF, WC offered by Ipca Laboratories

    Find a price of Atenolol bulk with DMF offered by Ipca Laboratories

    Find a price of Atovaquone bulk with CEP offered by Ipca Laboratories

    Find a price of Etodolac bulk with DMF offered by Ipca Laboratories

    Find a price of Lamotrigine bulk with CEP offered by Ipca Laboratories

    Find a price of Metformin bulk with DMF offered by Ipca Laboratories

    Find a price of Metoclopramide bulk with JDMF offered by Ipca Laboratories

    Find a price of Midodrine bulk with DMF offered by Ipca Laboratories

    Find a price of Ondansetron bulk with DMF offered by Ipca Laboratories

    Find a price of Risperidone bulk with DMF offered by Ipca Laboratories

    Find a price of Telmisartan bulk with CEP offered by Ipca Laboratories

    Find a price of Tramadol Hydrochloride bulk with CEP offered by Ipca Laboratories

    Find a price of Valsartan bulk with DMF offered by Ipca Laboratories

    Find a price of Zoledronic Acid bulk with JDMF offered by Ipca Laboratories

    Find a price of Amlodipine Besylate bulk with CEP offered by Ipca Laboratories

    Find a price of Amodiaquine Hydrochloride bulk offered by Ipca Laboratories

    Find a price of Artemether bulk offered by Ipca Laboratories

    Find a price of Artesunate bulk offered by Ipca Laboratories

    Find a price of Benzocaine bulk with WC offered by Ipca Laboratories

    Find a price of Bisoprolol Fumarate bulk with DMF offered by Ipca Laboratories

    Find a price of Bupropion Hydrochloride bulk with DMF offered by Ipca Laboratories

    Find a price of Celecoxib bulk with CEP offered by Ipca Laboratories

    Find a price of Cetirizine Dihydrochloride bulk with DMF offered by Ipca Laboratories

    Find a price of Cilostazol bulk offered by Ipca Laboratories

    Find a price of Clopidogrel bulk offered by Ipca Laboratories

    Find a price of Entacapone bulk with CEP offered by Ipca Laboratories

    Find a price of Famotidine bulk offered by Ipca Laboratories

    Find a price of Felodipine bulk with CEP offered by Ipca Laboratories

    Find a price of Furosemide bulk with JDMF offered by Ipca Laboratories

    Find a price of Hydrochlorothiazide bulk with CEP offered by Ipca Laboratories

    Find a price of Isotretinoin bulk offered by Ipca Laboratories

    Find a price of Levetiracetam bulk with CEP offered by Ipca Laboratories

    Find a price of Losartan Potassium bulk with DMF offered by Ipca Laboratories

    Find a price of Losartan Potassium bulk offered by Ipca Laboratories

    Find a price of Lumefantrine bulk offered by Ipca Laboratories

    Find a price of Metoprolol Succinate bulk with DMF offered by Ipca Laboratories

    Find a price of Metoprolol Tartrate bulk with DMF offered by Ipca Laboratories

    Find a price of Pantoprazole Sodium bulk offered by Ipca Laboratories

    Find a price of Pentoxifylline bulk offered by Ipca Laboratories

    Find a price of Perindopril Erbumine bulk offered by Ipca Laboratories

    Find a price of Piroxicam bulk with WC offered by Ipca Laboratories

    Find a price of Probenecid bulk with DMF offered by Ipca Laboratories

    Find a price of Promethazine Hydrochloride bulk offered by Ipca Laboratories

    Find a price of Quetiapine Hemifumarate bulk with CEP offered by Ipca Laboratories

    Find a price of Risedronate Sodium bulk with DMF offered by Ipca Laboratories

    Find a price of Risedronate Sodium bulk offered by Ipca Laboratories

    Find a price of Sacubitril-Valsartan bulk with WC offered by Ipca Laboratories

    Find a price of Silodosin bulk with WC offered by Ipca Laboratories

    Find a price of Sulfadoxine bulk offered by Ipca Laboratories

    Find a price of Tramadol Hydrochloride bulk offered by Ipca Laboratories

    Find a price of Trazodone Hydrochloride bulk with DMF offered by Ipca Laboratories

    Find a price of Trimethoprim bulk with DMF offered by Ipca Laboratories

    Find a price of Zaltoprofen bulk with JDMF offered by Ipca Laboratories

    Find a price of Zolpidem Tartrate bulk with WC offered by Ipca Laboratories

    Find a price of DULOXETINE HYDROCHLORIDE USP bulk with DMF offered by Ipca Laboratories

    Find a price of 2,4-Dichlorobenzyl Alcohol bulk offered by Ipca Laboratories

    Find a price of Alendronate Sodium bulk offered by Ipca Laboratories

    Find a price of Allopurinol bulk offered by Ipca Laboratories

    Find a price of Balsalazide Disodium bulk offered by Ipca Laboratories

    Find a price of CAS 103639-04-9 bulk offered by Ipca Laboratories

    Find a price of Dihydroartemisinin bulk offered by Ipca Laboratories

    Find a price of Erythromycin Estolate bulk offered by Ipca Laboratories

    Find a price of Escitalopram Oxalate bulk offered by Ipca Laboratories

    Find a price of Estradiol Valerate bulk offered by Ipca Laboratories

    Find a price of Eszopiclone bulk offered by Ipca Laboratories

    Find a price of Fluconazole bulk offered by Ipca Laboratories

    Find a price of Levofloxacin bulk offered by Ipca Laboratories

    Find a price of Levofloxacin Hemihydrate bulk offered by Ipca Laboratories

    Find a price of Lisinopril bulk offered by Ipca Laboratories

    Find a price of Mesalazine bulk offered by Ipca Laboratories

    Find a price of Metoclopramide Hydrochloride bulk offered by Ipca Laboratories

    Find a price of Morantel Citrate bulk offered by Ipca Laboratories

    Find a price of Nabumetone bulk offered by Ipca Laboratories

    Find a price of Nifedipine bulk offered by Ipca Laboratories

    Find a price of Norethisterone bulk offered by Ipca Laboratories

    Find a price of Norethisterone Acetate bulk offered by Ipca Laboratories

    Find a price of Propranolol Hydrochloride bulk offered by Ipca Laboratories

    Find a price of Pyrantel Pamoate bulk offered by Ipca Laboratories

    Find a price of Pyrantel Tartrate bulk offered by Ipca Laboratories

    Find a price of Ractopamine Hydrochloride bulk offered by Ipca Laboratories

    Find a price of Ritalinic Acid bulk offered by Ipca Laboratories

    Find a price of Testosterone bulk offered by Ipca Laboratories

    Find a price of Testosterone Propionate bulk offered by Ipca Laboratories

    Find a price of Testosterone Undecanoate bulk offered by Ipca Laboratories

    Find a price of Tibolone bulk offered by Ipca Laboratories

    Find a price of Triclabendazole bulk offered by Ipca Laboratories

    Find a price of Triclosan bulk offered by Ipca Laboratories

    Find a price of Zopiclone bulk offered by Ipca Laboratories

    Find a price of FACILITY IBD-D IN PIN., INDIA bulk offered by Ipca Laboratories

    Find a price of FACILITY FOR BULK DRUG PRODUCTION IN INDORE INDIA bulk offered by Ipca Laboratories

    Find a price of IBD-IV MANUFACTURING FACILITY IN RATLAM, INDIA bulk offered by Ipca Laboratories

    Find a price of Arteether bulk offered by Ipca Laboratories

    Find a price of Atenolol bulk offered by Ipca Laboratories

    Find a price of Benzocaine bulk offered by Ipca Laboratories

    Find a price of Carvedilol bulk offered by Ipca Laboratories

    Find a price of Cetirizine bulk offered by Ipca Laboratories

    Find a price of Cetirizine Dihydrochloride bulk offered by Ipca Laboratories

    Find a price of Chlorthalidone bulk offered by Ipca Laboratories

    Find a price of Citalopram bulk offered by Ipca Laboratories

    Find a price of Estradiol bulk offered by Ipca Laboratories

    Find a price of Glimepiride bulk offered by Ipca Laboratories

    Find a price of Hydroxychloroquine Sulphate bulk offered by Ipca Laboratories

    Find a price of Hydroxyzine Dihydrochloride bulk offered by Ipca Laboratories

    Find a price of Hydroxyzine Pamoate bulk offered by Ipca Laboratories

    Find a price of Nandrolone Phenpropionate bulk offered by Ipca Laboratories

    Find a price of Paroxetine Hydrochloride bulk offered by Ipca Laboratories

    Find a price of Phenylephrine Hydrochloride bulk offered by Ipca Laboratories

    Find a price of Piperaquine Phosphate bulk offered by Ipca Laboratories

    Find a price of Serratiopeptidase bulk offered by Ipca Laboratories

    Find a price of Simvastatin bulk offered by Ipca Laboratories

    Find a price of Sumatriptan bulk offered by Ipca Laboratories

    Find a price of Testosterone Cypionate bulk offered by Ipca Laboratories

    Find a price of Torsemide bulk offered by Ipca Laboratories

    Find a price of Trimethoprim bulk offered by Ipca Laboratories

    Find a price of Valsartan bulk offered by Ipca Laboratories

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search